Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 37 Supplement No. 1 Paroxetine Treatment of...

Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents

Psychopharmacology Bulletin 37(Suppl. 1) :167-175 , 2003/04/22

Abstract

This article provides an overview of the use of paroxetine in the treatment of mood and anxiety disorders in children and adolescents. Although not currently approved for use in patients younger than 18 years of age, the efficacy and safety of paroxetine have been studied in several pediatric mood and anxiety disorders. The epidemiology, diagnosis, and course of major depression, obsessive-compulsive disorder, social anxiety disorder, and panic disorder are discussed briefly. Current available data on the safety and efficacy of paroxetine based on double-blind, placebo-controlled trials and open-label studies for the treatment of mood and anxiety disorders in children and adolescents are reviewed. Clinical guidelines for the use of paroxetine in children and adolescents and recommendations regarding future directions of study are discussed.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Karen Dineen Wagner, MD, PhD. Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents. Psychopharmacology Bulletin. 2003/04/22; 37(Suppl. 1):167-175.